Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors

Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors

Near infrared photoimmunotherapy (NIR-PIT) is a newly developed and highly selective cancer treatment that employs a monoclonal antibody (mAb) conjugated to a photo-absorber dye, IRDye700DX, which is activated by 690 nm light. Cancer cell-targeted NIR-PIT induces rapid necrotic/immunogenic cell deat...

Full description

Bibliographic Details
Main Authors: Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L. Choyke, Hisataka Kobayashi
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
near infrared photoimmunotherapy
monoclonal antibodies
CD44
interleukin-15
cancer
Online Access:https://www.mdpi.com/2072-6694/12/9/2575

Internet

https://www.mdpi.com/2072-6694/12/9/2575

Similar Items